Genematrix Inc. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genematrix Inc. with three other
companies in this sector in South Korea:
sales of 6.86 billion Korean Won [US$6.10 million]
Cancer Rop Co Ltd
(4.67 billion Korean Won [US$4.15 million]
(4.83 billion Korean Won [US$4.29 million]
of which 100%
was Reagent & Cancer Diagnostic Kits).
Genematrix Inc. reported sales of 5.19 billion Korean Won (US$4.61 million)
December of 2017.
increase of 2.2%
versus 2016, when the company's sales were 5.08 billion Korean Won.
Despite this increase, sales are still
below the level achieved in 2015, when Genematrix Inc.
reported sales of 5.32 billion Korean Won.